Compare AMPG & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPG | NSPR |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.8M | 81.8M |
| IPO Year | N/A | N/A |
| Metric | AMPG | NSPR |
|---|---|---|
| Price | $3.47 | $1.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | ★ 631.1K | 108.2K |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $22,571,945.00 | $7,779,000.00 |
| Revenue This Year | $168.18 | $22.76 |
| Revenue Next Year | $100.00 | $75.45 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.47 | 14.04 |
| 52 Week Low | $0.85 | $1.59 |
| 52 Week High | $6.43 | $3.80 |
| Indicator | AMPG | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 39.98 |
| Support Level | $3.05 | $1.69 |
| Resistance Level | $3.59 | $1.93 |
| Average True Range (ATR) | 0.25 | 0.14 |
| MACD | 0.07 | 0.00 |
| Stochastic Oscillator | 85.37 | 27.27 |
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.